Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vsee Health (VSEE) EBITDA Margin (2023 - 2025)

Historic EBITDA Margin for Vsee Health (VSEE) over the last 3 years, with Q3 2025 value amounting to 51.69%.

  • Vsee Health's EBITDA Margin rose 16861600.0% to 51.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 63.57%, marking a year-over-year increase of 6614000.0%. This contributed to the annual value of 596.38% for FY2024, which is 5638900.0% down from last year.
  • Vsee Health's EBITDA Margin amounted to 51.69% in Q3 2025, which was up 16861600.0% from 66.51% recorded in Q2 2025.
  • Vsee Health's EBITDA Margin's 5-year high stood at 6.42% during Q1 2024, with a 5-year trough of 1737.85% in Q3 2024.
  • In the last 3 years, Vsee Health's EBITDA Margin had a median value of 54.25% in 2023 and averaged 197.48%.
  • Per our database at Business Quant, Vsee Health's EBITDA Margin crashed by -17132000bps in 2024 and then soared by 16861600bps in 2025.
  • Vsee Health's EBITDA Margin (Quarter) stood at 7.74% in 2023, then crashed by -948bps to 81.07% in 2024, then surged by 36bps to 51.69% in 2025.
  • Its EBITDA Margin was 51.69% in Q3 2025, compared to 66.51% in Q2 2025 and 55.14% in Q1 2025.